All About TALVEY (talquetamab) Published 2024-01-25 Download video MP4 360p Recommendations 22:21 TECVAYLI (Teclistamab) Everything You Need to Know 25:57 All About CARVYKTI 17:18 Low Sodium and How to Prevent Osmotic Demyelination Syndrome 22:50 My Multiple Myeloma Diagnosis: "They Weren't the Typical Symptoms" | Julie's Story 04:44 Investigating immune dynamics in multiple myeloma treated with talquetamab monotherapy 27:19 All about ELREXFIO (elranatamab) 14:28 All About Darzalex (daratumumab) 13:19 Using the Immune System to Fight Multiple Myeloma 15:13 How effective is Venetoclax? #AML 18:40 Matthew Perry's death from Ketamine explained (is it safe for you?) 1:02:49 A Nationwide Trial for Smoldering Myeloma Patients 17:55 Talquetamab | Therapies on the horizon 32:46 Erin's Multiple Myeloma Story: From Back Pain to a Stage 3 Diagnosis | The Patient Story 04:18 Why is knowing your free light chain ratio important? 1:10:32 Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals 31:34 2 - 6 Months to Live & the Cool Thing About Cancer 06:23 How Long Will I Live with Multiple Myeloma and is There a Cure? 23:13 Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute 26:11 MY HASHIMTOS STORY! | ANXIETY, DEPRESSION, WEIGHT GAIN, JOINT PAIN!? NATURAL APPROACH?! 11:42 What is Cytokine Release Syndrome? Similar videos 04:16 What is the monoclonal antibody TALVEY™ (talquetamab)? 07:01 FDA D.I.S.C.O. Burst Edition: FDA approvals of Talvey (talquetamab-tgvs) for relapsed or refracto... 03:44 What should myeloma patients know about talquetamab? 10:05 What Is the Impact of the Talquetamab Accelerated Approval in Multiple Myeloma? 03:10 Dr. Chari Discusses How He Manages Side Effects Related to Talquetamab 06:02 Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma 01:55 MonumenTAL-1: incidence of severe infections & parameters of humoral immunity with talquetamab 02:41 MonumenTAL-1: talquetamab for multiple myeloma 05:29 Updates on Teclistamab, Talquetamab, and CARVYKTI | Mark Wildgust, PHD | ASH 2022 07:01 Myeloma Panel Discusses 3 FDA-Approved Bispecific Agents: Talquetamab, Teclistamab, Elranatamab 04:15 Bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab 00:12 Talvey (talquetamab-tgvs) Injection #shorts 04:57 ASH 2022: Talquetamab Showing Promise in Multiple Myeloma Clinical Trial 01:44 TRIMM-2: talquetamab + daratumumab in patients with R/R multiple myeloma 00:11 US FDA Approves JNJ's TALVEY for Multiple Myeloma 01:00 The recent FDA approval of teclistamab for R/R multiple myeloma 01:14 Clinical benefit of teclistamab vs real-world physician’s choice for R/R multiple myeloma 03:08 What is the IMWG and what is its purpose in the field of myeloma research? More results